Dental Implant Clinical Trial
Official title:
Influence of Timing of Implant Placement on Early Healing Molecular Events: A Two-centre, Parallel Group, Pilot Study
Dental implants have been on the market for several years and they are routinely used to replace single/multiple missing teeth with a high success rate. However, there is still a limited number of studies comparing the influence of timing of implant placement on wound healing. In addition, there is no data available on the signaling pathways and the expression of healing biomarkers involved in the early stages of osseointegration after immediate implant placement (IP) or delayed implant placement (DP). The primary objective of this study is to describe changes in the expression of inflammatory, angiogenesis and osseous biomarkers of saliva at 1, 3, 7, 15 and 30 days and of PICF at 3, 7, 15 and 30 days after immediate implant placement (IP) compared with delayed placement (DP).
Status | Not yet recruiting |
Enrollment | 24 |
Est. completion date | May 30, 2026 |
Est. primary completion date | April 30, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 25 Years and older |
Eligibility | Inclusion Criteria: - Age =25 years old - Good/controlled medical and psychological health - Good oral hygiene (FMPS=20%) - Presence of a tooth in the aesthetic region (from incisor to second premolar) in need of extraction and further oral rehabilitation with a single dental implant. - For the IP group, the extraction socket should fulfil the following parameters, as described by the 5th ITI consensus [46]: intact socket wall; facial bone wall =1mm in thickness; no acute infection at the site; availability of bone apical and palatal to the socket to provide primary stability. - At least one neighbouring natural tooth. - A functional occlusion with a minimum of four occlusal units (i.e., pairs of occluding posterior teeth). - Willingness to read and sign a copy of the Informed Consent Form (ICF) after reading the Patient Information Sheet (PIS), and after the nature of the study has been fully explained and potential questions fully answered. Exclusion Criteria: - Any known systemic disease severely affecting bone metabolism (e.g., Cushing's syndrome, Crohn's disease, rheumatoid arthritis, osteoporosis or diabetes type I and uncontrolled diabetes type II). - Self-reported HIV or viral hepatitis. - Self-reported alcoholism or chronic drug abuse. - Smokers (including current smokers or former smokers who had quit for < 3 months); patients reporting use of vape/e-cigarettes will also be excluded. - Self-reported pregnancy or lactation (this criterion is due to oral tissue changes related to pregnancy and nursing, which can affect interpretation of study results). - Chronic treatment (i.e., 2 weeks or more) with any medication known to affect oral status or bone metabolism (e.g., bisphosphonates, hormone replacement therapy, immunosuppressants) within 1 month before baseline visit. - Chronic treatment with anticoagulants (including Aspirin), corticosteroids, immunosuppressants or other medications that may influence blood coagulation/count. - Antibiotic or anti-inflammatory therapy during the month preceding the baseline exam. - Untreated caries lesions and untreated/uncontrolled periodontal disease; If patients require periodontal treatment (non-surgical and/or surgical), this will be arranged outside the study protocol and completed prior to enrolment; - Inadequate keratinized tissue width (<2 mm) in the mid-buccal aspect of the area to be treated in the study. - Physical handicaps that would interfere with the ability to perform adequate oral hygiene in the area of implant placement. - Patients requiring maxillary sinus lift surgery before implant placement. - Self-reported bruxism. - Patients not willing to receive animal-derived biomaterials for GBR. - Patients suffering from a known psychological disorder or with limited mental capacity or language skills such that study information could not be understood, informed consent could not be obtained, or simple instructions could not be followed. - Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase the risk associated with trial participation or may interfere with the interpretation of trial results and, in the judgement of the investigator, would make the subject inappropriate for entry into this trial. |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Centre for Oral Clinical Research | London |
Lead Sponsor | Collaborator |
---|---|
Queen Mary University of London | University of Zurich |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in the expression of inflammatory, angiogenesis and osseous biomarkers of PICF and saliva | The expression of inflammatory, angiogenesis and osseous biomarkers of PICF at 3, 7, 15 and 30 days after immediate implant placement (IP) or delayed placement (DP) and of saliva at day 1, 3, 7, 15 and 30 | 1, 3, 7, 15 and 30 days after immediate or delayed implant placement | |
Secondary | Blood flow changes | Blood flow changes immediately after, at 1, 3, 7, 15 and 30 days after implant placement | immediately after, 1, 3, 7, 15 and 30 days after immediate or delayed implant placement | |
Secondary | Soft tissue volume changes | Soft tissue volume changes immediately after, at 1, 3, 7, 15, 30 days and 3 months after immediate or delayed implant placement, at loading and 6 months after implant loading | immediately after,1, 3, 7, 15, 30 days and 3 months after immediate or delayed implant placement, at loading and 6 months after implant loading | |
Secondary | Peri-implant bone level | Peri-implant bone level 6 months after loading, using CBCT images | 6 months after implant loading | |
Secondary | Full mouth plaque score (FMPS) | FMPS will be recorded as a percentage of total surfaces (6 sites per tooth/implant), which reveal the presence of plaque. A binary score will be assigned to each surface (1 for plaque present, 0 for absent). | 6 months after implant loading | |
Secondary | Full mouth bleeding score (FMBS) | FMBS will be recorded as percentage of total surfaces (6 aspects per tooth/implant), which reveal the presence of bleeding within 10 - 30 seconds following periodontal probing. A binary score will be assigned to each surface (1 for bleeding present, 0 for bleeding absent). | 6 months after implant loading | |
Secondary | Probing pocket depth (PPD) | PPD will be measured in mm using a University of North Carolina (UNC-15) periodontal probe at six sites per tooth/ implant (i.e., mesiobuccal, buccal, distobuccal, mesiolingual, lingual, and distolingual). | 6 months after implant loading | |
Secondary | Gingival recession (REC) | REC will be measured in mm using a University of North Carolina (UNC-15) periodontal probe at six sites per tooth/ implant (i.e., mesiobuccal, buccal, distobuccal, mesiolingual, lingual, and distolingual). | 6 months after implant loading | |
Secondary | Clinical attachment level (CAL) | CAL will be calculated considering the values for PPD and REC in mm | 6 months after implant loading | |
Secondary | Suppuration | Suppuration will be recorded as percentage of total surfaces (6 aspects per tooth/implant), which reveal the presence of suppuration following periodontal probing. A binary score will be assigned to each surface (1 for suppuration present, 0 for suppuration absent). | 6 months after implant loading | |
Secondary | Patient satisfaction at 6 months after loading | Patient satisfaction regarding the overall implant treatment using a subjective outcome questionnaire at 6 months post loading. | 6 months after implant loading | |
Secondary | Changes in the pink esthetic score (PES) | Changes in the pink esthetic score (PES) from loading to 6 months after loading | 6 months after implant loading | |
Secondary | Changes in the white esthetic score (WES) | Changes in the white esthetic score (WES) from loading to 6 months after loading | 6 months after implant loading | |
Secondary | Changes in the papilla fill index (PFI) | Changes in the papilla fill index (PFI) from loading to 6 months after loading | 6 months after implant loading | |
Secondary | Implant survival | Implant functionally present in the mouth | 6 months after implant loading |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05053958 -
Using Superimposition of Intra-Oral Scan and CBCT in Single Implant Restorations in Aesthetic Zone.
|
N/A | |
Recruiting |
NCT04367766 -
Management of the Fresh Extraction Socket in the Aesthetic Area
|
N/A | |
Recruiting |
NCT06296459 -
Radiographic Changes in the Maxillary Sinus Following Closed Sinus Augmentation
|
N/A | |
Recruiting |
NCT06247098 -
Evaluation of Sinus Augmentation Bone Healing Using Autograft and Xenograft Compared to Xenograft Alone
|
N/A | |
Not yet recruiting |
NCT05988281 -
Success of Implant Restorations After Immediate or Delayed Implant Placement With/Without Ridge Preservation
|
N/A | |
Completed |
NCT04340830 -
The Effect of Smoking on Dimensional Changes of Free Gingival Graft Around Dental Implants
|
N/A | |
Completed |
NCT06404385 -
Accuracy of Static Computer-assisted Implant Surgery in Distal Free-end Scenarios
|
N/A | |
Recruiting |
NCT05405179 -
Simultaneous Dental Implant in Free Vascularized Bone Flaps for Jaw Reconstruction
|
N/A | |
Completed |
NCT06138392 -
Long-term Study in Early Loaded Hydrophilic Surface Implants
|
||
Completed |
NCT04332679 -
Non-resorbable Membranes Versus Titanium Meshes and Resorbable Membranes
|
N/A | |
Completed |
NCT06127576 -
Biomechanical Informational Effect of Innovative Double or Triple Dental Abutment-implant: Case-series
|
||
Recruiting |
NCT06059573 -
The Accuracy of Dental Implant Placement Using Robotic System-assisted Surgery and Freehand Surgery
|
N/A | |
Recruiting |
NCT06068231 -
A Study of Early Loading of Implants in the Maxillary Anterior Region With Alveolar Bone Defects
|
N/A | |
Completed |
NCT03774888 -
To Compare Different Soft Tissue Grafts at the Time of Lateral Ridge Augmentation Procedure.
|
N/A | |
Completed |
NCT02864862 -
Esthetic Outcomes Following Immediate Implant Combine With Soft Tissue Augmentation
|
Phase 4 | |
Completed |
NCT02444052 -
Evaluation of Zimmer Puros® Allograft vs. Creos™ Allograft for Alveolar Ridge Preservation
|
N/A | |
Completed |
NCT04861662 -
Effect of Keratinized Mucosa on Peri-implant Health
|
N/A | |
Not yet recruiting |
NCT04541641 -
Clinical Evaluation of Stability of Implants Placed in Partially Edentulous Maxilla With Poor Bone Quality Via New Reverse Drilling Technique Versus Osteotome Technique.
|
N/A | |
Completed |
NCT03888339 -
Influence of Abutment Shape on Peri-implant Marginal Bone Loss
|
N/A | |
Recruiting |
NCT06231134 -
Diode Laser 940 nm Versus Electrosurgical Device During Second Stage Implant Surgery on Bone and Soft Tissue Healing
|
N/A |